Changes in norovirus incidence in Victoria, Australia, during the COVID-19 pandemic, 2020–2021
DOI:
https://doi.org/10.33321/cdi.2022.46.61Keywords:
norovirus, viral gastroenteritis, childcare, outbreak, genotypes, COVID-19 restrictionsAbstract
There were 142 norovirus positive outbreaks in Victoria for the 2020–2021 calendar years; however, almost half of these (48.6%) occurred in Q1 (January–March) of 2021. For the two-year period, 69.0% of all norovirus positive outbreaks were in childcare settings, and the predominant genotype was GII.P16/GII.2 (64.9%) followed by GII.P31/GII.4_2012 (20.9%). Norovirus incidence was particularly low in 2020 (n = 26) and close to average in 2021 (n = 116), but genotype diversity was low in both years. With the thought that 2022 will approach a more normal aspect to socialising and travel, norovirus incidence in 2022 may be predicted to increase above typical levels.
Downloads
References
Lucero Y, Matson DO, Ashkenazi S, George S, O’Ryan M. Norovirus: facts and reflections from past, present, and future. Viruses. 2021;13(12):2399. doi: https://doi.org/10.3390/v13122399.
Victoria State Government Department of Health. Guidelines for the investigation of gastroenteritis for Environmental Health Officers. [Internet.] Melbourne: Victoria State Government Department of Health; 4 December 2020. [Accessed on 28 June 2022.] Available from: https://www.health.vic.gov.au/publications/guidelines-for-the-investigation-of-gastroenteritis-for-environmental-health-officers.
Dunbar NL, Bruggink LB, Marshall JA. Evaluation of the RIDAGENE real-time PCR assay for the detection of GI and GII norovirus. Diagn Microbiol Infect Dis. 2014;79(3):317–21. doi: https://doi.org/10.1016/j.diagmicrobio.2014.03.017.
Judd Boaz. Melbourne passes Buenos Aires’ world record for time spent in COVID-19 lockdown. [Internet.] Sydney: Australian Broadcasting Corporation, ABC News; 3 Octobet 2021. [Accessed on 12 January 2022.] Available from: https://www.abc.net.au/news/2021-10-03/melbourne-longest-lockdown/100510710.
Bidalot M, Théry L, Kaplon J, De Rougemont A, Ambert-Balay K. Emergence of new recombinant noroviruses GII.p16-GII.4 and GII.p16-GII.2, France, winter 2016 to 2017. Euro Surveill. 2017;22(15):30508. doi: https://doi.org/10.2807/1560-7917.es.2017.22.15.30508.
Kwok K, Niendorf S, Lee N, Hung T-N, Chan L-Y, Jacobson S et al. Increased detection of emergent recombinant norovirus GII.P16–GII.2 strains in young adults, Hong Kong, China, 2016–2017. Emerg Infect Dis. 2017;23(11):1852–5. doi: https://doi.org/10.3201/eid2311.170561.
Barclay L, Cannon JL, Wikswo ME, Phillips AR, Browne H, Montmayeur AM et al. Emerging novel GII.P16 noroviruses associated with multiple capsid genotypes. Viruses. 2019;11(6):535. doi: https://doi.org/10.3390/v11060535.
O’Reilly KM, Sandman F, Allen D, Jarvis CI, Gimma A, Douglas A et al. Predicted norovirus resurgence in 2021–2022 due to the relaxation of nonpharmaceutical interventions associated with COVID-19 restrictions in England: a mathematical modeling study. BMC Med. 2021;19(1):299. doi: https://doi.org/10.1186/s12916-021-02153-8.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
